I. Y. Bagmut, “Hyperglobulinemia as a marker in the development of immune deficiency and complications in inflammatory breast cancer patients with type 2 diabetes mellitus”, RJDNMD, vol. 29, no. 4, pp. 389-394, Nov. 2022.